27
Apr
2008
27
Apr
2008
27
Apr
2008
05
Feb
2008
Posted in I - Series C, Q - 1Q08, R - NORTH WEST, X - Antibody
Alder Biopharma (Bothell, WA) developer of unique antibody technologies that may increase antibody potency, accelerate production cycles, and lower production costs closed a $40M Series C financing. Participants include Delphi Ventures, TPG Biotech, Sevin Rosen Funds, Ventures West, H.I.G. Ventures, and WRF Capital.